Literature DB >> 21182915

In vivo anti-tussive activity and structural features of a polysaccharide fraction from water extracted Withania somnifera.

Sharmistha Sinha1, Gabriella Nosál'ová, Shruti S Bandyopadhyay, Dana Flešková, Bimalendu Ray.   

Abstract

AIM OF THE STUDY: Anti-tussive drugs are amongst the most widely used medications worldwide; however no new class of drugs has been introduced into the market for many years. The present study aims at evaluating the structural features and in vivo anti-tussive activity of a polysaccharide fraction from water extracted Withania somnifera.
MATERIALS AND METHODS: Herein, we have analyzed water extracted material of Withania somnifera using chemical, chromatographic, spectroscopic and biological methods.
RESULTS: A polysaccharide fraction (F3) containing arabinosyl, galactosyl and galacturonosyl residues were obtained by anion exchange chromatography of the water extracted material. This polymer is branched and contained (1,5)-/(1,3,5)-linked arabinofuranosyl, (1,3)-/(1,6)-/(1,3,6)-linked galactopyranosyl residues together with small amount of terminal rhamnopyranosyl and terminal arabinofuranosyl residues. Peroral administration of this pectic arabinogalactan in a dose of 50 mg kg(-1) body weight (b.w.) decreased the number of cough efforts induced by citric acid in guinea pigs like that of codeine.
CONCLUSIONS: This study provides a scientific basis for the past and present ethnomedical uses of this plant.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182915     DOI: 10.1016/j.jep.2010.12.022

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  1 in total

1.  Antitussive Activity of the Water-Extracted Carbohydrate Polymer from Terminalia chebula on Citric Acid-Induced Cough.

Authors:  Gabriela Nosalova; Ludovit Jurecek; Udipta Ranjan Chatterjee; Sujay Kumar Majee; Slavomir Nosal; Bimalendu Ray
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.